Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.
about
Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitorsNF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy targetImaging mass spectrometry of intact proteins from alcohol-preserved tissue specimens: bypassing formalin fixation.Mast cells mediate malignant pleural effusion formation.Development of a rabbit pleural cancer model by using VX2 tumors.Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner.[Establishment of a malignant pleural effusion mouse model with Lewis lung carcinoma cell lines expressing enhanced green fluorescent protein].Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in miceBeneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinoma.Multivariate modelling with (1)H NMR of pleural effusion in murine cerebral malariaPleural involvement in lung cancer.Opposing effects of bortezomib-induced nuclear factor-κB inhibition on chemical lung carcinogenesis.Visualization of Fra-1/AP-1 activation during LPS-induced inflammatory lung injury using fluorescence optical imaging.A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells.Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis.Bioluminescence imaging.The angiopoietin/Tie2 axis mediates malignant pleural effusion formationIcmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion.Translational advances in pleural malignancies.Malignant pleural effusion: tumor-host interactions unleashed.The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications.Switching off malignant pleural effusion formation-fantasy or future?Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.Influence of AQP1 on cell adhesion, migration, and tumor sphere formation in malignant pleural mesothelioma is substratum- and histological-type dependent.Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo.Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer.Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.Protective effects of mastic oil from Pistacia lentiscus variation chia against experimental growth of lewis lung carcinoma.A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.Zoledronic acid is effective against experimental malignant pleural effusion.Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomasEstablishment of a malignant pleural effusion mouse model with lewis lung carcinoma cell lines expressing enhanced green fluorescent protein.Establishment of a malignant pleural effusion mouse model: pathogenesis pathways.Monoclonal antibody targeting of mononuclear cell chemokines driving malignant pleural effusion.Malignant pleural effusion: further translational research is crucial.Differentiated expression of the lactate dehydrogenase subunit M in pleural fluids of neoplastic aetiology.Malignant pleural effusions: fixing the leaky faucet.
P2860
Q28475474-8FC9A8E9-D88B-46FD-9BF7-A2A8D5D785FCQ28611413-4F0445BA-EB91-49CA-BB17-8E52AF404337Q30479892-C30E4C5F-7218-4F21-8088-4E8DA408D0ECQ30657333-3562033C-7595-467D-B6D2-F16CF73BFA22Q33347764-6668244A-E09E-4D14-A17C-86809839B3EBQ33737084-925AF55C-5647-46FB-A8F0-511A55ABBFD3Q33925776-E2F6266C-A5F8-47F0-BD27-B9020EED4413Q34297841-910D95B1-BF67-4033-B614-EE529B50C920Q34402445-0E1D3770-FC8C-44BD-B43F-AE20FC3071DBQ34535252-4C37A538-8760-4F2B-ACF8-FE71A7533FE9Q34963525-8E79D8E6-AF05-4DC2-AA3B-B1B3FB8164EFQ35005521-213E8AAB-2F4E-4557-9E40-5A6FAAF75902Q35586924-0401C61F-2906-4B41-B0A4-BA66C6CDADD7Q35739559-52AFD5B3-3365-4C49-8F67-72836F04A184Q35883572-19F4BABF-6B84-41A0-98FB-825E6433C7CDQ35959840-EF3A91AC-26BE-4D6F-B69B-DC2A409BB73EQ36066547-EF6F3281-8776-47B6-920F-AE84F07576C3Q36276848-9E6CEC39-E65B-4C14-9889-9A9072B94FA1Q36341235-4825AE22-74B8-4B68-BD7D-145BF0089068Q37109566-615BCDE3-9F38-4D47-AA64-174EC4C3E9BFQ37190280-5380316D-9121-4360-972C-A2C13A544B3EQ37806309-EEB9D15B-3F3D-4041-B37E-FF35ABBA3AAFQ38015001-7E24F098-941D-4C5B-A416-F6E87FE31216Q38058513-20D717E8-E81F-44C3-9581-4F9A07399240Q38543525-09616025-91F4-4435-8C0E-E34B09E25157Q38585167-DBE6989E-DBF9-4E8F-A0C1-BDE54C43DBD6Q38803126-9457D5A2-112E-4705-A5EC-F94E624E4894Q38846141-6C30F177-6B0A-4135-8CF4-DB4593A516B2Q38938729-1D40A4D0-8681-4D24-BAAA-0A4BBF68FC6BQ39389185-C37C56FE-24BA-4BD4-A73E-75FC7553E3EBQ39786074-EDE80123-A3CD-4658-B4B6-0E0EB24ADD15Q39931549-4A715E0A-D72B-4FE6-8FB3-58FC8A10FD78Q39995123-C9058E94-8F69-45F5-A9BB-81154C9AEF7EQ41855478-D9151888-B586-4A3D-B3CD-A014A37320E5Q41978764-EB9FC4AB-60F8-4ADE-A010-073D49F83D0FQ42220280-95CCAF79-3899-49FD-82FA-B3F87E6689A4Q42745376-7C752284-6059-42F8-9C1F-6435E8F79013Q43195730-9E3BB08D-9CAC-443F-AD25-1131B5168727Q46343723-CCD10087-9A76-4A92-B474-5937B84EB939Q46530300-57D3DBBB-786D-4012-B9A4-E6DB55F4443A
P2860
Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 October 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nuclear factor-kappaB affects ...... of malignant pleural effusion.
@en
Nuclear factor-kappaB affects ...... of malignant pleural effusion.
@nl
type
label
Nuclear factor-kappaB affects ...... of malignant pleural effusion.
@en
Nuclear factor-kappaB affects ...... of malignant pleural effusion.
@nl
prefLabel
Nuclear factor-kappaB affects ...... of malignant pleural effusion.
@en
Nuclear factor-kappaB affects ...... of malignant pleural effusion.
@nl
P2093
P2860
P356
P1476
Nuclear factor-kappaB affects ...... of malignant pleural effusion
@en
P2093
Daphne Mitchell
Fiona E Yull
Ioannis Kalomenidis
M Brett Everhart
Richard W Light
Semra Bilaceroglu
Timothy S Blackwell
William E Lawson
Zhiwen Zhu
P2860
P304
P356
10.1165/RCMB.2005-0130OC
P577
2005-10-06T00:00:00Z